Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 Evaluation of AG-920 (Cyklx) for Ophthalmic Anesthesia
NCT04829344Phase 3Completed
- Sponsor
- American Genomics
- Start
- Mar 2021
- Primary completion
- May 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of tranexamic acid in procedural pain, sponsored by American Genomics. Started Mar 2021; status: completed.
02
Drugs
tranexamic acid
03
Conditions
procedural pain
Beyond the preview
Go deeper on NCT04829344.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04829344.